In the wake of the coronavirus pandemic, many Americans are worried about their health insurance. The cost of treating the illness, if a patient ends up in the ICU, can run into the tens of thousands of dollars without coverage. Which most people just can’t afford. Today we bring you a piece we produced last year about a related topic -the rising cost of insulin, and the effectiveness of medicare for all. First, we visit a group of community scientists called the Open Insulin Project, an organization trying to create its own insulin outside the lengthy FDA process and whether it's worth the associated risks. And we talk about the benefits of Medicare for All, a policy which would get rid of private insurance and make all medicine and medical care accessible and affordable.